Perception of COVID-19 vaccines in rheumatology patients.

Loading...
Thumbnail Image
Identifiers

Publication date

Authors

Romero Bogado, Liz
Steiner, Martina
Cobo Ibáñez, María Tatiana

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Since the development of vaccines for coronavirus disease 2019 (COVID-19), the course of infections has changed significantly. Over the past 4 years of coexisting with the virus, a marked improvement in disease outcomes has been observed, especially in patients with rheumatological diseases; this is largely attributable to widespread immunization. This study aimed to evaluate the perception of COVID-19 vaccine protection and to describe the incidence and severity of COVID-19 in the pre- and post-vaccination periods among different patient typologies and immunosuppressive treatments in rheumatology patients. This study used observational, descriptive–analytical, ambispective, and cross-sectional methods.

Description

Keywords

Bibliographic reference

Romero-Bogado, L., Steiner, M., Andreu-Vázquez, C., Thuissard-Vasallo, I. J., Cobo-Ibáñez, T., De La Cámara-Fernández, I., Esteban-Vázquez, A., Paredes-Romero, M. B., Richi-Alberti, P., Trives-Folguera, L., Vergara-Dangond, C., Castañeda, E., Acosta-Alfaro, A. V., Cueva-Nájera, G., Sánchez-Díaz, R., Puerto-Muñoz, E., & Muñoz-Fernández, S. (2025). Perception of COVID-19 vaccines in rheumatology patients. Medicine, 104(31), e43618. https://doi.org/10.1097/MD.0000000000043618

Type of document

Attribution-NonCommercial 4.0 International

La licencia de este ítem se describe como Attribution-NonCommercial 4.0 International